spacer
home > ebr > spring 2002 > interim management within life science companies
PUBLICATIONS
European Biopharmaceutical Review

Interim Management Within Life Science Companies

Reaching what are often well publicised milestones, or striving to gain or retain a competitive advantage is very much about taking calculated risks, about making decisions where the outcome is less than certain. If there is a successful outcome, the hero is born - if only for a day. If companies do stumble somewhat, then let us applaud the fact that there was courage enough for a decision in the first place. Then let us learn and move forward.

But What if Progress is Hindered Due to Avoidable Causes?

It is people who make decisions, and who subsequently implement them, and in today's tough and unforgiving marketplace, the absence of experienced and competent individuals within an organisation is now rightly deemed to be unacceptable. Indeed, the permanent recruitment of high quality staff is critical and does take time, but not having the right people in the right place - exactly when they are needed - is simply not acceptable anymore.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Geoff Newman, Managing Director of Interea International Ltd

Geoff Newman is the Co-Founder and Managing Director of Interea International, a provider of senior level Interim Management to the UK and international life sciences sector. Geoff graduated with First Class Honours in Chemistry from Durham University, before joining the pharmaceutical industry.
His career has encompassed commercial and general management roles within a number of companies, and has included significant overseas postings in Switzerland, Japan and the US.

spacer
Geoff Newman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the 11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement